MTVA
Metavia Inc.
$1.62+0.03 (1.89%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Gemphire Therapeutics Inc. (GEMP) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
9 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-12 | Woodworth Marshall H | CFO | Gift | 14,200 | $0.00 | $0 | N/A | N/A |
| 2025-07-01 | 2025-06-30 | Salsbury Michael | Director | Award | 28,147 | $0.00 | $0 | N/A | N/A |
| 2025-07-01 | 2025-06-30 | Koven Andrew I | Director | Award | 28,147 | $0.00 | $0 | N/A | N/A |
| 2025-07-01 | 2025-06-30 | Strickland D Gordon | Director | Award | 28,147 | $0.00 | $0 | N/A | N/A |
| 2025-07-01 | 2025-06-30 | Tursi James Patrick | Director | Award | 28,147 | $0.00 | $0 | N/A | N/A |
| 2025-07-01 | 2025-06-30 | Groves Jason L | Director | Award | 28,147 | $0.00 | $0 | N/A | N/A |
| 2025-07-01 | 2025-06-30 | Glickman Mark A | Director | Award | 28,147 | $0.00 | $0 | N/A | N/A |
| 2025-06-04 | 2025-06-04 | Woodworth Marshall H | CFO | Purchase | 14,200 | $0.70 | $9,940 | +1082.9% | +918.6% |
| 2025-05-20 | 2025-05-08 | Dong-A St Co., Ltd | 10% Owner | Purchase | 4,647,887 | $0.71 | $3,300,000 | +946.5% | +971.8% |
MTVA
10% Owner
Purchase
$3.3M
Dong-A St Co., Ltd4,647,887 shares @ $0.71
Filed 2025-05-20Trade 2025-05-08